Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Dec. 25, 2021	Dec. 26, 2020
Cash flows from operating activities:
Net income	$ 229,941	$ 192,063
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	45,156	35,478
Stock-based compensation expense	49,368	42,069
Deferred income taxes	(8,243)	3,679
Loss on retirement or write-off of long-lived assets	527	52
Other non-cash adjustments	282	124
MEMS restructuring charges	0	352
Net change in operating assets and liabilities:
Accounts receivable, net	(210,694)	(90,806)
Inventories	32,413	4,036
Long-term prepaid wafers	(195,000)	0
Other assets	(101,160)	(3,529)
Accounts payable and other accrued liabilities	(12,720)	6,157
Income taxes payable	159	(13,233)
Acquisition-related liabilities	36,493	0
Net cash (used in) provided by operating activities	(133,478)	176,442
Cash flows from investing activities:
Maturities and sales of available-for-sale marketable securities	366,582	97,415
Purchases of available-for-sale marketable securities	(77,716)	(153,505)
Purchases of property, equipment and software	(18,091)	(11,734)
Investments in technology	(3,463)	(1,310)
Acquisition of business, net of cash obtained	(276,884)	0
Net cash used in investing activities	(9,572)	(69,134)
Cash flows from financing activities:
Debt issuance costs	(1,718)	0
Issuance of common stock, net of shares withheld for taxes	8,562	6,487
Repurchase of stock to satisfy employee tax withholding obligations	(18,335)	(13,619)
Repurchase and retirement of common stock	(92,502)	(65,001)
Net cash used in financing activities	(103,993)	(72,133)
Net (decrease) increase in cash and cash equivalents	(247,043)	35,175
Cash and cash equivalents at beginning of period	442,164	292,119
Cash and cash equivalents at end of period	$ 195,121	$ 327,294